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Abstract
Introduction Post-traumatic stress disorder (PTSD) has been
identified in a significant portion of intensive care unit (ICU)
survivors. We sought to identify factors associated with PTSD
symptoms in patients following critical illness requiring
mechanical ventilation.
Methods Forty-three patients who were mechanically ventilated
in the medical and coronary ICUs of a university-based medical
center were prospectively followed during their ICU admission
for delirium with the Confusion Assessment Method for the ICU.
Additionally, demographic data were obtained and severity of
illness was measured with the APACHE II (Acute Physiology
and Chronic Health Evaluation II) score. Six months after
discharge, patients were screened for PTSD symptoms by
means of the Post-Traumatic Stress Syndrome 10-Questions
Inventory (PTSS-10). Multiple linear regression was used to
assess the association of potential risk factors with PTSS-10
scores.
Results At follow-up, six (14%) patients had high levels of PTSD
symptoms. On multivariable analysis, women had higher PTSS-
10 scores than men by a margin of 7.36 points (95%
confidence interval [CI] 1.62 to 13.11; p = 0.02). Also, high
levels of PTSD symptoms were less likely to occur in older
patients, with symptoms declining after age 50 (p  = 0.04).
Finally, although causation cannot be assumed, the total dose of
lorazepam received during the ICU stay was associated with
PTSD symptoms; for every 10-mg increase in cumulative
lorazepam dose, PTSS-10 score increased by 0.39 (95% CI
0.17 to 0.61; p = 0.04). No significant relationship was noted
between severity of illness and PTSD symptoms or duration of
delirium and PTSD symptoms.
Conclusion High levels of PTSD symptoms occurred in 14% of
patients six months following critical illness necessitating
mechanical ventilation, and these symptoms were most likely to
occur in female patients and those receiving high doses of
lorazepam. High levels of PTSD symptoms were less likely to
occur in older patients.
APACHE II = Acute Physiology and Chronic Health Evaluation II; CAM-ICU = Confusion Assessment Method for the Intensive Care Unit; CI = con-
fidence interval; ICU = intensive care unit; PTSD = post-traumatic stress disorder; PTSS-10 = Post-Traumatic Stress Syndrome 10-Questions Inven-
tory; SF-12 = Short Form Health Survey-12.Critical Care    Vol 11 No 1    Girard et al.
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Introduction
The life-sustaining therapies employed in the intensive care
unit (ICU) commonly result in pain and anxiety as reported by
survivors of critical illness [1,2]. In addition, the acute illnesses
that threaten each patient's life create formidable stress.
These experiences may result in long-term morbidity in survi-
vors of critical illness, including depression, anxiety, and other
psychological disorders [3]. One such psychological out-
come, post-traumatic stress disorder (PTSD), has been iden-
tified in a significant portion of ICU survivors [4]. Early
identification of patients who are at high risk for the develop-
ment of PTSD after critical illness may facilitate the implemen-
tation of strategies focused on preventing this untoward
outcome.
The current literature offers little in the way of identification of
patients at high risk for PTSD after critical illness. Although
female gender has long been recognized as a risk factor for
the development of PTSD [5,6], the significance of gender on
the development of PTSD after critical illness remains unclear.
One recent study determined that ICU patients subjected to a
daily interruption of sedatives developed fewer symptoms of
PTSD [7]. Also, recent work has shown that ICU patients with
delusional memories of their ICU stay are more likely to
develop PTSD than those with factual memories [8]. Critical ill-
ness is frequently complicated by delirium [9], and delusions
are a common component of delirium, suggesting that delirium
may be associated with the development of PTSD. However,
no previous studies of PTSD after critical illness have incorpo-
rated formal evaluations of delirium.
Therefore, this pilot investigation was conducted to identify
factors associated with the development of PTSD symptoms
in patients after critical illness. Specifically, we hypothesized
that ICU delirium is a risk factor for the development of PTSD
symptoms following critical illness and mechanical ventilation.
Materials and methods
Subjects
All patients who required mechanical ventilation and were
admitted to the medical and coronary care ICUs of the 631-
bed Vanderbilt University Medical Center (Nashville, TN, USA)
between 21 February and 3 May 2001 were prospectively
evaluated for enrollment. Those with neurologic disease
impairing cognitive function (for example, stroke and Parkin-
son's disease) or mental retardation were excluded, as were
non-English speakers and those with sensory deficits limiting
their ability to communicate with examiners. Although no his-
tory of PTSD was identified at enrollment, it is possible that
some study patients had pre-existing PTSD that was not
reported; due to the non-elective nature of their ICU admis-
sions, patients were not prospectively assessed for symptoms
of PTSD prior to enrollment. The study was approved by the
Vanderbilt University Institutional Review Board, and informed
consent was obtained from the patients or their surrogates
before study enrollment. Consent was also obtained from all
patients at the six month follow-up visit. Although no outcomes
data from this manuscript have been previously reported, other
data from this cohort have been published [9-12].
Procedures
Baseline data included demographics, ICU admission diag-
noses, and data needed to calculate the Acute Physiology and
Chronic Health Evaluation II (APACHE II) score [13] and the
Charlson Comorbidity Index (calculated by the method of
Deyo and colleagues [14]). While in the ICU, patients were
evaluated daily for delirium with the Confusion Assessment
Method for the ICU (CAM-ICU) [9,15]. The CAM-ICU had a
high sensitivity (93% to 100%), specificity (89% to 100%),
and inter-rater reliability (κ, 0.96; 95% confidence interval [CI]
0.92 to 0.99) when evaluated against a reference standard
rater in two cohorts of medical ICU patients. Each dose of sed-
ative (lorazepam, midazolam, and propofol) and analgesic (fen-
tanyl and morphine) medication received was recorded daily
throughout the ICU stay.
Follow-up testing was conducted six months after hospital dis-
charge; this interval was arbitrarily defined a priori. Patients
were screened for PTSD symptoms by means of the modified
Post-Traumatic Stress Syndrome 10-Questions Inventory
(PTSS-10) [16]. This two-part questionnaire assesses for
memories of traumatic experiences during the ICU stay: night-
mares, panic, pain, and suffocation (part A). It then measures
the intensity of 10 PTSD symptoms presently experienced
(that is, at or around the time of evaluation) by the patient (part
B), including sleep disturbance, nightmares, depression, hype-
ralertness, emotional numbing, irritability, labile mood, guilt,
avoidance of activities prompting recall of the traumatizing
event, and muscular tension; each symptom is rated from 1
(never) to 7 (always). Total scores of more than 35 on part B
predict the diagnosis of PTSD by the criteria outlined in the
DSM-III (Diagnostic and Statistical Manual of Mental Disor-
ders, Third Edition) [16]. The PTSS-10 has a high sensitivity
(77%) and specificity (97.5%) and has been validated for use
in ICU patients, with a reliability coefficient (Crohnbach's
alpha) of 0.914 in this patient population [4,16]. Quality of life
was assessed by means of the Short Form Health Survey-12
(SF-12) [17], and a comprehensive neuropsychological bat-
tery was performed [11]. The PTSS-10, SF-12, and the neu-
ropsychological battery were conducted in person by a
neuropsychologist (SMG) or a clinical psychologist (JCJ).
Terminology
Although a PTSS-10 score of more than 35 predicts the diag-
nosis of PTSD [16], this screening instrument cannot make a
formal diagnosis of PTSD. Because formal psychiatric evalua-
tions were not carried out, results are reported in terms of
PTSD symptoms rather than a diagnosis of PTSD.Available online http://ccforum.com/content/11/1/R28
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Statistical analysis
Baseline characteristics are presented using median and inter-
quartile range for continuous variables and proportions for cat-
egorical variables. Patients evaluated at the six month follow-
up and those not tested at six months were compared by
means of Wilcoxon rank-sum tests for continuous variables
and Fisher exact tests for categorical variables. Spearman
rank correlations were employed to evaluate the correlations
between PTSS-10 score and duration of delirium (defined as
the total days of delirium measured in the ICU), age in years,
APACHE II score, cumulative dose of sedative drug (defined
as the total amount of drug received during the ICU stay sep-
arately for lorazepam, midazolam, morphine, fentanyl, and pro-
pofol), total days in the ICU, total days of mechanical
ventilation, the presence of memories of traumatic ICU experi-
ences (PTSS-10, part A), quality of life as measured by SF-12
scores, and composite neuropsychological test scores. A Wil-
coxon rank-sum test was used to compare PTSS-10 scores
among men and women.
To assess the independent association of each factor with
PTSD symptoms, multiple linear regression was employed
with PTSS-10 score as the outcome variable. Although a
threshold value of 35 on the PTSS-10 has been recom-
mended in order to maximize sensitivity and specificity, higher
PTSS-10 scores across the spectrum of possible scores (10
to 70) are associated with a higher likelihood of diagnosing
PTSD [16], making the PTSS-10 score a suitable continuous
outcome variable. A priori, we chose to include age in years
[18], gender [5], APACHE II score, sedative exposure [7], and
days of delirium [8] in the regression model because, based
on existing literature and clinical suspicion, we suspected
these factors to be associated with PTSD. To assess the asso-
ciation between sedative exposure and PTSD symptoms,
cumulative lorazepam dose was chosen based on the Spear-
man correlation analysis; compared with cumulative fentanyl
and propofol doses, cumulative lorazepam dose was corre-
lated most with PTSS-10 scores. Because of their possible
correlation with cumulative sedative drug dose, total days in
the ICU and days of mechanical ventilation were not included
in the model. No variables were removed from the model. Non-
linear associations between each continuous variable and
PTSS-10 score were assessed by including non-linear cubic
splines in the regression model. Non-linearity of the effect of
age was included in the regression model because significant
non-linearity was detected in its association with the outcome.
To correct for possible overfitting of the regression model,
penalized maximum likelihood estimation was used to allow
shrinkage for non-linear effect of age. Residuals of the multiple
linear regression model were examined by graphically plotting
residuals against predicted values, plotting normal Q-Q plots,
and using the Shapiro-Wilk test. Additionally, bootstrap model
validation was used to assess the robustness of the regres-
sion model for its predictability for future data. R software ver-
sion 2.11 [19], SAS version 9.0 (SAS Institute Inc., Cary, NC,
USA), and SPSS version 14 (SPSS Inc., Chicago, IL, USA)
were used for data analysis, and a two-sided 5% significance
level was used for all statistical inferences.
Results
Of 555 mechanically ventilated ICU patients admitted during
the study period, 275 (49.5%) patients were enrolled in the
study. A total of 280 patients were excluded: 86 had stroke or
another primary neurologic disorder, 13 were deaf or unable
to understand English, 44 died prior enrollment, 69 were extu-
bated prior to enrollment, 27 had been previously enrolled, and
consent was not obtained for 41 patients [12]. After enroll-
ment, 96 patients died prior to hospital discharge. Of the
remaining 179 patients, 23 (13%) patients died within six
months of discharge, 27 (15%) were too ill to participate in fol-
low-up evaluation or declined further participation, and 86
(48%) patients were lost to follow-up. Therefore, a total of 43
(24%) patients were evaluated six months after hospital dis-
charge (Table 1). There were no significant differences in
baseline demographics or outcome measures between the
patients tested at the six-month follow-up and those not tested
(for example, due to death or illness or lost to follow-up),
except that hepatic and renal failure were more common in
those tested (p = 0.003).
At the six-month follow-up, 6 (14%) of 43 patients scored
more than 35 on the PTSS-10 (Figure 1) (that is, reported high
levels of symptoms consistent with PTSD). These patients
reported frequent feelings of guilt (83%), mood swings (67%),
and sleep disturbances (67%). Muscular tension was the
symptom experienced least often (16% of patients reported
frequent muscular tension). The majority of patients with PTSD
symptoms at six months reported memories of panic (67%)
and suffocation (50%) during the ICU stay, whereas memories
of nightmares (20%) and severe pain (20%) were less com-
mon. Spearman rank correlation coefficients (rho) between
PTSS-10 score and cumulative doses of sedative drugs were
0.30 for lorazepam (p = 0.05), -0.22 for midazolam (p = 0.16),
0.09 for fentanyl (p = 0.56), 0.07 for morphine (p = 0.66), and
-0.16 for propofol (p  = 0.30). Thus, cumulative lorazepam
dose is included in the multivariable model.
Results of the multivariable analysis are shown in Table 2.
Women had higher PTSS-10 scores than men by a margin of
7.36 points (95% CI 1.62 to 13.11; p = 0.02). PTSD symp-
toms were less likely to occur in older patients, with symptoms
declining after age 50 (p = 0.04) (Figure 2). The total dose of
lorazepam received during the ICU stay was associated with
PTSD symptoms; for every 10-mg increase in lorazepam dose,
PTSS-10 score increased by 0.39 (95% CI 0.17 to 0.61; p =
0.04). Bootstrap validation indicated that overfitting by the
regression model was minimal (2.3%), suggesting excellent
robustness of prediction in future patients.Critical Care    Vol 11 No 1    Girard et al.
Page 4 of 8
(page number not for citation purposes)
No significant correlation between PTSD symptoms and dura-
tion of delirium or APACHE II scores was demonstrated (Table
2). Additionally, PTSD symptoms were not significantly corre-
lated with duration of mechanical ventilation (Spearman's rho,
0.034; p = 0.83) or with duration of ICU stay (Spearman's rho,
0.10;  p  = 0.51). Thus, the observed association between
cumulative lorazepam dose and PTSD symptoms does not
seem to be confounded by duration of ICU stay or mechanical
ventilation. As expected, the presence of memories of trau-
matic ICU experiences (PTSS-10, part A) was positively cor-
related with PTSD symptoms (PTSS-10, part B) (Spearman's
rho, 0.366; p = 0.02). Additionally, there was a significant
inverse correlation between PTSD symptoms and quality of life
as measured by SF-12 scores (Spearman's rho, -0.565; p <
0.0001). There was no correlation noted between PTSD
symptoms and composite neuropsychological test scores
(Spearman's rho, -0.079; p = 0.63).
Discussion
In this investigation, high levels of PTSD symptoms after criti-
cal illness requiring mechanical ventilation were most likely to
occur in female patients and in patients treated with high
doses of lorazepam, whereas PTSD symptoms were less likely
to occur in older patients. Understanding these risk factors
may facilitate preventive strategies and direct screening for
symptoms of PTSD after critical illness. In this study, 14% of
patients evaluated six months after discharge reported high
levels of symptoms consistent with PTSD. This coincides with
the existing literature that reports a prevalence of 10% to 30%
[4,7,16,18,20-25]. Despite occurring frequently, PTSD goes
unrecognized in many patients. The current study confirms
previous work showing that high levels of PTSD symptoms are
associated with impaired quality of life [4], underscoring the
importance of diagnosing and treating this disorder in survi-
vors of critical illness.
In this study, women were significantly more likely than men to
have high levels of PTSD symptoms after critical illness. The
association between PTSD and female gender has been
reported previously [5], but few studies have evaluated the sig-
nificance of gender on the development of PTSD after critical
illness. Several studies have demonstrated that women are
Table 1
Baseline characteristics and ICU outcomes for patients evaluated at six months and those not tested
six-month follow-up Not tested
Characteristics (n = 43) (n = 136) p valuea
Age in years, median (IQR) 52 (39–65) 55 (42–68) 0.39
Female, percentage (number/total) 53 (23/43) 49 (66/136) 0.60
Black, percentage (number/total) 16 (7/43) 24 (33/136) 0.40
Charlson Comorbidity Index, median (IQR) 3 (2–5) 3 (1–5) 0.34
APACHE II score, median (IQR) 25 (20–31) 25 (18–31) 0.63
ICU admission diagnosisb, percentage (number/total)
Sepsis and/or acute respiratory distress syndrome 42 (18/43) 49 (66/136) 0.49
Pneumonia 26 (11/43) 15 (21/136) 0.17
Myocardial infarction/Congestive heart failure 9 (4/43) 9 (12/136) 1.00
Hepatic or renal failure 12 (5/43) 1 (1/136) 0.003
COPD 2 (1/43) 10 (14/136) 0.12
Gastrointestinal bleeding 2 (1/43) 10 (14/136) 0.12
Malignancy 5 (2/43) 2 (3/136) 0.59
Drug overdose 5 (2/43) 7 (9/136) 1.00
Other 21 (9/43) 34 (46/136) 0.13
ICU length of stay in days, median (IQR) 10 (5–13) 7 (5–10) 0.08
Days on mechanical ventilation, median (IQR) 5 (3–12) 6 (3–9) 0.61
Duration of coma in days, median (IQR) 1 (0–3) 1 (0–2) 0.16
Duration of delirium in days, median (IQR) 2 (1–3) 2 (1–3) 0.39
ap values were obtained using Wilcoxon rank-sum tests for all variables except female and black/white, for which Fisher exact tests were used. 
bPrimary and secondary admission diagnoses are included, resulting in some patients being listed twice (for example, as having both sepsis and 
COPD). APACHE II, Acute Physiology and Chronic Health Evaluation II; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; 
IQR, interquartile range.Available online http://ccforum.com/content/11/1/R28
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more vulnerable to PTSD, even after controlling for differences
in the type of trauma [5,6], and a higher incidence of pre-exist-
ing anxiety and/or depression disorders is postulated to play
some role in the difference in PTSD rates between the sexes
[6].
This study reveals a significant relationship between age and
PTSD symptoms, with older patients being less likely to expe-
rience high levels of PTSD symptoms after critical illness. A
non-linear relationship between age and PTSD symptoms was
observed, but caution is appropriate in interpreting this finding
because of the small number of younger patients studied and
the results of previous research. For example, Scragg and col-
leagues [18] evaluated 80 ICU patients for symptoms of
PTSD and reported that scores on the screening instrument
were inversely correlated with age (p = 0.05). Rattray and col-
leagues [23] similarly found that symptoms of anxiety (p =
0.04) and avoidance (p = 0.01) were inversely correlated with
age 12 months after discharge in 80 ICU survivors. In the cur-
rent study, older patients were significantly less likely than mid-
dle-aged patients to have high levels of PTSD symptoms.
Several possible explanations for this relationship exist.
Although each patient studied was mechanically ventilated,
older patients are less likely to receive aggressive interven-
tions that may predispose them to the development of PTSD
[26]. Additionally, given that older patients may have multiple
comorbidities and a history of hospitalization, they may be less
likely to view critical illness as a traumatic event.
We hypothesized that patients who experienced longer peri-
ods of delirium would be more likely to develop high levels of
PTSD symptoms after critical illness, but the data do not sup-
port this hypothesis. Jones and colleagues [8] have demon-
strated that the recall of delusions rather than factual
memories of the ICU experience is associated with the devel-
opment of PTSD symptoms. Their study assessed 45 patients
after ICU discharge and revealed that patients with delusional
memories and no recall of factual events in the ICU were more
likely to develop PTSD symptoms than those patients with fac-
tual memories (p < 0.0001). These data [8] suggest that peri-
Figure 1
Distribution of PTSS-10 [16] scores at six-month follow-up Distribution of PTSS-10 [16] scores at six-month follow-up. Median = 
21; interquartile range = 14 to 30; range = 10 to 61. Vertical dashed 
line indicates the recommended threshold above which patients are 
considered to be displaying high levels of post-traumatic stress disor-
der symptoms. PTSS-10, Post-Traumatic Stress Syndrome 10-Ques-
tions Inventory.
Table 2
Factors associated with post-traumatic stress disorder symptoms at six-month follow-up
Univariate analysisa Multivariable analysisb
Factor rho p value B (95% CI) p value
Age in years -0.297 0.05 Non-linear effectc 0.04
APACHE II 0.039 0.80 0.02 (-0.32, 0.37) 0.90
Duration of delirium in days 0.030 0.84 0.91 (-0.82, 2.63) 0.31
Total lorazepam dose (in 10 mg intervals) 0.300 0.05 0.39 (0.17, 0.61) 0.001
Female gender 7.36 (1.62, 13.11) 0.02
Median PTSS-10 score (IQR) by gender
Female 22 (16–35) 0.06d
Male 17 (12–27)
aSpearman correlation coefficients (rho) unless otherwise noted. bMultiple linear regression with B representing regression coefficients. cSee 
Figure 2. dWilcoxon rank-sum tests were used. APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, confidence interval; IQR, 
interquartile range; PTSS-10, Post-Traumatic Stress Syndrome 10-Questions Inventory.Critical Care    Vol 11 No 1    Girard et al.
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ods of delirium, with associated delusions, may predispose
patients to PTSD whereas periods of alertness, which allow
for the consolidation of factual memories, may protect patients
from developing PTSD-related symptoms after discharge.
However, the association between days of delirium and PTSD
symptoms in this study was not statistically significant (p =
0.31).
Cumulative lorazepam dose correlated with PTSD symptoms.
Although Nelson and colleagues [27] studied 24 survivors of
acute respiratory distress syndrome and noted that days of
sedation correlated with symptoms of both PTSD (p = 0.006)
and depression (p = 0.007), the current investigation is the
first to report an association between sedative dose and PTSD
symptoms. However, it cannot be concluded from these anal-
yses that lorazepam causes PTSD. The possibility exists that
ICU patients who demonstrate symptoms of anxiety during
their ICU stay are likely to receive higher sedative doses than
those patients who are not anxious. Therefore, high lorazepam
doses may identify those ICU patients with acute stress disor-
der, a known risk factor for PTSD [28].
Although the administration of lorazepam may lead to more
PTSD symptoms or alternatively may identify anxious ICU
patients, the daily interruption of sedatives may facilitate peri-
ods of alertness and reduce the risk of PTSD. Kress and col-
leagues [7] evaluated 32 patients who were randomly
assigned to the daily interruption of sedatives or standard
sedation to determine the long-term psychological effects of
this intervention. The 13 patients who had been treated with
daily interruption of sedation had better Impact of Events
scores (11.2 versus 27.3, p = 0.02) and a lower incidence of
PTSD (0% versus 32%, p = 0.06). Further study of the effect
of the daily interruption of sedation on the development of
PTSD is needed.
Limitations of the current study warrant comment. Because
the PTSS-10 does not make a formal diagnosis of PTSD, the
results of this study may not be generalizable to the clinical
syndrome of PTSD. Also, the PTSS-10 does not assess for
delusional memories. Data on the frequency of delusional
memories, such as those provided by the ICU Memory tool
[29], would have allowed for more in-depth analysis regarding
the relationship between delusional memories, delirium, and
PTSD symptoms. There were a significant number of patients
lost to follow-up. Analysis suggests that baseline and outcome
characteristics were similar between those patients lost to fol-
low-up and those evaluated at six months (Table 1), but this
does not rule out the possibility of selection bias. In fact,
'avoidance of activities prompting recall of traumatizing events'
is a symptom of PTSD, and patients experiencing this symp-
tom may have been less likely to return for follow-up testing.
Thus, this study may underestimate the prevalence of PTSD
after critical illness. Also, the findings regarding risk factors
might have differed if all survivors had been evaluated. It was
not systematically determined whether any patient sought psy-
chiatric care prior to the six-month follow-up, and follow-up
was limited to a single visit. Therefore, it is possible that some
patients experienced PTSD symptoms prior to follow-up but
that psychiatric treatment resulted in the resolution of such
symptoms prior to testing at six months. Also, no evidence
exists to define the ideal follow-up interval after which to
screen for PTSD symptoms. Therefore, it is possible that
screening after a shorter interval would have identified a higher
number of patients with PTSD symptoms. Because of the non-
elective nature of critical illness, it could not be prospectively
confirmed that patients did not have PTSD prior to ICU admis-
sion. This diagnosis was not reported by family members and
was not recorded in the medical record for the patients in this
study. Finally, no data were collected regarding corticosteroid
and beta-blocker administration, two possible confounders
[30,31]. This planned pilot investigation was limited by a small
sample size, and a larger study to confirm these findings is
warranted.
Conclusion
This study shows that high levels of PTSD symptoms occurred
in one out of every seven patients six months following critical
illness and mechanical ventilation. High levels of PTSD symp-
Figure 2
Adjusted effect of age on PTSS-10 score Adjusted effect of age on PTSS-10 score. The solid line indicates the 
predicted PTSS-10 score based on a patient's age after adjustment 
using multiple linear regression for APACHE II score, gender, cumula-
tive lorazepam dose, and days of delirium. The dashed lines indicate the 
95% confidence interval for the regression line. P = 0.04 for the effect 
of age and p = 0.04 for non-linearity, indicating PTSS-10 scores 
increase as age increases up to 50 years, after which PTSS-10 scores 
decrease as age increases. APACHE II, Acute Physiology and Chronic 
Health Evaluation II; PTSS-10, Post-Traumatic Stress Syndrome 10-
Questions Inventory.Available online http://ccforum.com/content/11/1/R28
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toms were most likely to occur in females and less likely to
occur in older patients. Additionally, lorazepam dose in the
ICU was associated with PTSD symptoms at follow-up,
although causation cannot be assumed. A significant minority
of patients who survive critical illness will develop symptoms
of PTSD; screening for these symptoms and warning all
patients about the possibility of experiencing such symptoms
is prudent. Knowledge of the risk factors demonstrated in this
study may facilitate identification of PTSD after critical illness.
However, it is unclear what component (or components) of
ICU experience (for example, the critical illness itself or treat-
ments rendered) may contribute to the development of PTSD.
The current data cannot help to answer this question, and this
is an important area to be addressed by future studies. Also,
additional studies are needed before firm conclusions can be
made regarding the relationship between ICU delirium and the
development of PTSD after critical illness.
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